These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16144537)

  • 21. Behavioural adjustment in seizure-free epilepsy patients on monotherapy.
    Hessen E; Lossius MI; Gjerstad L
    Seizure; 2008 Jul; 17(5):422-30. PubMed ID: 18243738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodologies used to identify and characterize interactions among antiepileptic drugs.
    Johannessen Landmark C; Patsalos PN
    Expert Rev Clin Pharmacol; 2012 May; 5(3):281-92. PubMed ID: 22697591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Spanish version of the Liverpool Adverse Events Profile in patients with epilepsy.
    Carreño M; Donaire A; Falip M; Maestro I; Fernández S; Nagel AG; Serratosa J; Salas J; Viteri C; Llorens J; Baró E
    Epilepsy Behav; 2009 Jun; 15(2):154-9. PubMed ID: 19435575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended-release lamotrigine in the treatment of patients with epilepsy.
    Syed TU; Sajatovic M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1579-85. PubMed ID: 20482306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment of epilepsy: options and limitations.
    Schmidt D
    Epilepsy Behav; 2009 May; 15(1):56-65. PubMed ID: 19236951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters.
    Panayiotopoulos CP; Benbadis SR; Covanis A; Dulac O; Duncan JS; Eeg-Olofsson O; Ferrie CD; Grünewald RA; Kasteleijn-Nolst Trenite DG; Koutroumanidis M; Martinovic Z; Newton RW; Parker AP; Salas-Puig J; Sander JW; Shorvon S; Watanabe K; Whitehouse WP; Youroukos S
    Epilepsia; 2004 Dec; 45(12):1646-9; author reply 1649-51. PubMed ID: 15571526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cognitive impairment in childhood epilepsy: the role of antiepileptic drugs].
    Tich SN; Péréon Y
    Epileptic Disord; 2001; 3 Spec No 2():SI87-93. PubMed ID: 11827851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selecting the first drug in children and adolescents with epilepsy: evidence versus personal experience].
    Herranz JL
    Rev Neurol; 2012 May; 54 Suppl 3():S1-5. PubMed ID: 22605626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of epilepsy: pharmacologic therapy and quality-of-life issues.
    Schachter SC; Yerby MS
    Postgrad Med; 1997 Feb; 101(2):133-8, 141-4, 150-3. PubMed ID: 9046932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview on antiepileptic drugs.
    Das N; Dhanawat M; Shrivastava SK
    Drug Discov Ther; 2012 Aug; 6(4):178-93. PubMed ID: 23006988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for drug treatment of epilepsy: a critical review.
    Guerreiro CA
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):591-9. PubMed ID: 18813732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant drugs: indications and guidelines for use in epilepsy.
    Schmitz B
    Epilepsia; 2002; 43 Suppl 2():14-8. PubMed ID: 11903477
    [No Abstract]   [Full Text] [Related]  

  • 33. The goal of epilepsy therapy: no seizures, no side effects, as soon as possible.
    Engel J
    CNS Spectr; 2004 Feb; 9(2):95-7. PubMed ID: 14999165
    [No Abstract]   [Full Text] [Related]  

  • 34. Commission on Outcome Measurement in Epilepsy, 1994-1997: final report.
    Baker GA; Camfield C; Camfield P; Cramer JA; Elger CE; Johnson AL; Martins da Silva A; Meinardi H; Munari C; Perucca E; Thorbecke R
    Epilepsia; 1998 Feb; 39(2):213-31. PubMed ID: 9578003
    [No Abstract]   [Full Text] [Related]  

  • 35. Author Response: Does Screening for Adverse Effects Improve Health Outcomes in Epilepsy? A Randomized Trial.
    Franco V; Perucca E
    Neurology; 2021 Mar; 96(13):639. PubMed ID: 33782166
    [No Abstract]   [Full Text] [Related]  

  • 36. Reader Response: Does Screening for Adverse Effects Improve Health Outcomes in Epilepsy? A Randomized Trial.
    Bruzzone M
    Neurology; 2021 Mar; 96(13):638. PubMed ID: 33782165
    [No Abstract]   [Full Text] [Related]  

  • 37. Statistical efficiency of patient data in randomized clinical trials of epilepsy treatments adds value.
    Romero J; Goldenholz DM
    Epilepsia; 2020 Oct; 61(10):2323-2324. PubMed ID: 32996130
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinician's guide to randomized trials: interpretation.
    Thabane A; Phillips MR; Wong TY; Thabane L; Bhandari M; Chaudhary V;
    Eye (Lond); 2022 Mar; 36(3):481-482. PubMed ID: 35058599
    [No Abstract]   [Full Text] [Related]  

  • 39. Translating clinical trials into practice.
    Channer KS
    Lancet; 1997 Mar; 349(9052):654. PubMed ID: 9057761
    [No Abstract]   [Full Text] [Related]  

  • 40. News from the CDC: translating epilepsy self-management research to practice.
    Kobau R; Price PH; Hawkins NA
    Transl Behav Med; 2012 Jun; 2(2):124-5. PubMed ID: 24073104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.